Sangamo Therapeutics

SGMO

SGMO Sangamo Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    SGMO Chart
    See on advanced chart >

    About

    Sangamo Therapeutics, Inc. was incorporated in the State of Delaware on June 22, 1995 and is focused on the development and commercialization of novel transcription factors for gene regulation and gene modification. Sangamo Biosciences,was a clinical stage...
    • Highlight
      A leading gene therapy company with a strong pipeline of treatments for rare genetic diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      04/06/2000
    • Established Date
      06/22/1995
    • Full-time Employees
      405
    • Address
      501 Canal Blvd. Richmond California 94804
    • Tel
      1-510-9706000
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock